Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection
- PMID: 22257755
- PMCID: PMC3274429
- DOI: 10.1186/1743-422X-9-23
Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection
Abstract
Hepatocyte nuclear factors 4 alpha (HNF4α) and 3 beta (HNF3β) are members of a group of liver-enriched transcription factors (LETFs) that play important roles in regulating the replication of hepatitis B virus (HBV) and liver inflammation. However, the relationship of the level of HNF4α and HNF3β with the severity of HBV-infected liver diseases is unclear. In this study, liver tissue samples from different types of HBV patients were collected, and HNF4α and HNF3β expression were detected by immunohistochemistry. The expression of HNF4α was significant higher in patients with severe hepatitis B(SHB) than those with chronic hepatitis B(CHB) and liver cirrhosis(LC) (both P < 0.05), but similar between patients with CHB and LC (P > 0.05). And the expression of HNF3β was similar among patients with CHB, LC and SHB (P > 0.05 for all pairwise comparison). This suggests that the expression level of HNF4α was different in patients with different outcome of HBV infection, high expression level of HNF4α may correlate with occurrence of SHB.
Figures
Similar articles
-
Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.J Biol Chem. 2015 Jan 9;290(2):1170-85. doi: 10.1074/jbc.M114.601203. Epub 2014 Nov 24. J Biol Chem. 2015. PMID: 25422324 Free PMC article.
-
Intrahepatic IFN-alpha expression in liver specimens from HBV-infected patients with different outcomes.Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2474-80. Eur Rev Med Pharmacol Sci. 2013. PMID: 24089226
-
The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients.J Viral Hepat. 2009 Aug;16(8):537-46. doi: 10.1111/j.1365-2893.2009.01089.x. Epub 2009 Feb 26. J Viral Hepat. 2009. PMID: 19302415
-
Natural history of chronic hepatitis B virus infection: an immunopathological study.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S218-22. doi: 10.1111/j.1440-1746.1997.tb00503.x. J Gastroenterol Hepatol. 1997. PMID: 9407340 Review.
-
Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.Curr Top Microbiol Immunol. 1996;206:149-73. doi: 10.1007/978-3-642-85208-4_9. Curr Top Microbiol Immunol. 1996. PMID: 8608715 Review.
Cited by
-
Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver.Cancers (Basel). 2021 Oct 26;13(21):5357. doi: 10.3390/cancers13215357. Cancers (Basel). 2021. PMID: 34771521 Free PMC article. Review.
-
GATA binding protein 4 promotes the expression and transcription of hepatitis B virus by facilitating hepatocyte nuclear factor 4 alpha in vitro.Virol J. 2021 Sep 28;18(1):196. doi: 10.1186/s12985-021-01668-z. Virol J. 2021. PMID: 34583732 Free PMC article.
-
Antiviral Activity of Interferon Alpha-Inducible Protein 27 Against Hepatitis B Virus Gene Expression and Replication.Front Microbiol. 2021 Mar 31;12:656353. doi: 10.3389/fmicb.2021.656353. eCollection 2021. Front Microbiol. 2021. PMID: 33868214 Free PMC article.
-
Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation.Int J Mol Sci. 2020 Jan 31;21(3):948. doi: 10.3390/ijms21030948. Int J Mol Sci. 2020. PMID: 32023898 Free PMC article.
-
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.Acta Pharmacol Sin. 2020 Feb;41(2):278-285. doi: 10.1038/s41401-019-0302-0. Epub 2019 Sep 25. Acta Pharmacol Sin. 2020. PMID: 31554961 Free PMC article.
References
-
- Blum HE. Hepatitis B virus: significance of naturally occurring mutants. Intervirology. 1993;35:40–50. - PubMed
-
- Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, Antona D, Bovet M, Mechain M, Asselah T, Desenclos JC, Jougla E. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008;48:200–207. doi: 10.1016/j.jhep.2007.09.010. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical